Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial. (Q53028018)

10 May 2018

title

Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial. (English)

1 reference

10 May 2018

1 reference

Kernan WN

1 reference

10 May 2018

Brass LM

1 reference

10 May 2018

Viscoli CM

1 reference

10 May 2018

Sarrel PM

1 reference

10 May 2018

Makuch R

1 reference

10 May 2018

Horwitz RI

1 reference

10 May 2018

publication date

1 January 1998

1 reference

10 May 2018

Journal of Stroke and Cerebrovascular Diseases

published in

1 reference

10 May 2018

volume

1 reference

10 May 2018

issue

1 reference

10 May 2018

page(s)

85-95

1 reference

10 May 2018

Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

A prognostic system for transient ischemia or minor stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Survival and recurrence following stroke. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Natural history of stroke in Rochester, Minnesota, 1955 through 1969: an extension of a previous study, 1945 through 1954.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal oestrogen treatment and stroke: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen use and stroke risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen use, hypertension and stroke in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Ovarian hormones and the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The heart: a target organ for estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen-binding sites in endothelial cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

How do we explain the clinical benefits of estrogen? From bedside to bench

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Oestrogens, arterial status, and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen modulates responses of atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Postmenopausal oestrogen and cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Uncertainty about postmenopausal estrogen. Time for action, not debate

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effects of Conjugated Equine Estrogen With and Without Three Different Progestogens on Lipoproteins, High-Density Lipoprotein Subfractions, and Apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Biologic effects of transdermal estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Risks and benefits of replacement estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogens in the prevention of osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Conjugated estrogen use and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Endometrial cancer and estrogen use. Report of a large case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogens and Endometrial Cancer in a Retirement Community

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The menopause: benefits and risks of estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen replacement therapy and the risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Estrogen and the risk of coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Effect of ovarian hormones on the uterine vascular bed

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Performance-oriented assessment of mobility problems in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

1 reference

7 January 2021

Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

A pilot study of the end point verification system in the asymptomatic carotid atherosclerosis study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Vaginosonography for early detection of endometrial carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The role of vaginal scan in measurement of endometrial thickness in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Endometrial thickness and Doppler velocimetry of the uterine arteries as discriminators of endometrial status in women with postmenopausal bleeding: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Diagnostic dilation and curettage: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Detection of postmenopausal women at risk for endometrial carcinoma by a progesterone challenge test

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Progesterone challenge test for the assessment of endometrial pathology in asymptomatic menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

Adjusted survival curve estimation using covariates.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

An improved approximate formula for calculating sample sizes for comparing two binomial distributions

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3057%2898%2980026-8

7 January 2021

10.1016/S1052-3057(98)80026-8

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018